The mandate of the CCM is to discuss, approve and submit viable and appropriate proposals to the Global Fund, and to monitor, evaluate and support the implementation of projects that are initiated by the CCM and financed by the Global Fund.
The CCM has the following responsibilities:
Develop, modify and implement these Terms of Reference.
Prepare, coordinate, review, and submit project proposals to the Global Fund that meet the requirements of the Global Fund and that are in line with national AIDS, tuberculosis, and malaria priorities and programs.
Respond to inquiries from the Global Fund concerning these proposals.
Propose to the Global Fund who should be the Principal Recipient(s) ("PR(s)") for CCM-initiated projects financed by the Global Fund.
Choose the Sub-Recipient(s) ("SR(s)") for these projects, except when the CCM delegates this responsibility to the PR(s).
Monitor and evaluate the performance of the PR(s).
Monitor and evaluate the performance of the SR(s), except when the CCM delegates this responsibility to the PR(s).
Approve major changes in program implementation plans and budgets.
When necessary, submit to the Global Fund requests for continued funding for each approved grant, prior to the end of the two years of initially approved financing.
Carry out an annual evaluation of the effectiveness of the CCM.
06 February 2025 - Oversight Committee Meeting
06 March 2025 - CCM General Meeting
11-19 March 2025 - Global Fund Country team visit to PNG
Window 5 Submission - Deadline 29 April 2024
29 April 2024
PNG recently submitted to Global Fund the TB HIV Funding Request Proposal Application (GC7) for 2025-2026.
Submission of Grants approved by the Global Fund
23 November 2023
Global Fund Board approval: PNG-M-RAM for the 2024-2026 implementation cycle.
20 December 2023
Global Fund Board approval: PNG TB/HIV grant extension for 2024
GF approval: C19RM reprogramming request
The Global Fund Board has approved the grant extension for the TB/HIV grant (PNG-C-WV) for 2024 and the Global Fund Secretariat has approved the C19RM reinvestment of savings.
___________________________________________________